Qiong Zhou

12PUBLICATIONS
10CO-AUTHORS
Molecular targetsTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 02, 2026
First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFR-mutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial.

Fan Zhang, Zhendong Zheng, Hongmei Zhang

|Jan 20, 2026
Huaier Aqueous Extract Combined with Gefitinib Promotes ACSL4-Dependent Ferroptosis and Overcomes Gefitinib Resistance in Non-Small Cell Lung Cancer.

Yi-Heng Du, Pei Zhang, Qian-Qian Xue

|May 09, 2025
Tumor cell-intrinsic circular RNA circFNDC3B attenuates CD8+ T cells infiltration in non-small cell lung cancer.

Xiaoshan Wei, Xuan Xiang, Haolei Wang

|Dec 25, 2024
Lactylation-driven TNFR2 expression in regulatory T cells promotes the progression of malignant pleural effusion.

Qianqian Xue, Wenbei Peng, Siyu Zhang

|Aug 21, 2023
C1q+ tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion.

Siyu Zhang, Wenbei Peng, Haolei Wang

|Jan 13, 2023
Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell-based Therapy.

Zi-Hao Wang, Qiong Zhou

Pageof 2

Frequent Collaborators

2 joint publications

Huanzhong Shi

2 joint publications

Zi-Hao Wang

2 joint publications

Wenbei Peng

1 joint publications

Yujun Chang